Current status of human immunodeficiency virus and hepatitis C virus (HIV/HCV) co-infection in Cameroon: Sero-prevalence, risk factors and correlation with markers of liver function and CD4 cells rate in patients diagnosed in three hospital settings

Djuidje Ngounoue Marceline; Guiateu Tamo Ida Marlene; Ambassa Axel Cyriaque; Fepa Kwesseu GaÃ«lle Armelle; Moundipa Fewou Paul

doi:10.5897/JAHR2017.0456

Journal of
AIDS and HIV Research

Abbreviation: J. AIDS HIV Res.
Language: English
ISSN: 2141-2359
DOI: 10.5897/JAHR
Start Year: 2009
Published Articles: 299

Full Length Research Paper

Current status of human immunodeficiency virus and hepatitis C virus (HIV/HCV) co-infection in Cameroon: Sero-prevalence, risk factors and correlation with markers of liver function and CD4 cells rate in patients diagnosed in three hospital settings

Djuidje Ngounoue Marceline

Djuidje Ngounoue Marceline
Department of Biochemistry, Faculty of Science, University of YaoundÃ© I, Cameroon.
Search for this author on:
Google Scholar

Guiateu Tamo Ida Marlene

Guiateu Tamo Ida Marlene
Department of Biochemistry, Faculty of Science, University of YaoundÃ© I, Cameroon.
Search for this author on:
Google Scholar

Ambassa Axel Cyriaque

Ambassa Axel Cyriaque
Department of Biochemistry, Faculty of Science, University of YaoundÃ© I, Cameroon.
Search for this author on:
Google Scholar

Fepa Kwesseu GaÃ«lle Armelle

Fepa Kwesseu GaÃ«lle Armelle
Department of Biochemistry, Faculty of Science, University of YaoundÃ© I, Cameroon.
Search for this author on:
Google Scholar

Moundipa Fewou Paul

Moundipa Fewou Paul
Department of Biochemistry, Faculty of Science, University of YaoundÃ© I, Cameroon.
Search for this author on:
Google Scholar

Article Number - E5B341656169
Vol.10(3), pp. 22-30 , March 2018
https://doi.org/10.5897/JAHR2017.0456

Received: 04 December 2017
Accepted: 19 January 2018
Published: 31 March 2018

References

Ankouane F, Noah Noah D, Atangana MM, Kamgaing Simo R, Guekam PR, Biwolé Sida M (2016). Seroprevalence of hepatitis B and C viruses, HIV-1/2 and syphilis among blood donors in the Yaoundé Central Hospital in the centre region of Cameroon. Transfus Clin. Biol. 23(2):72-77. Crossref

Cameroon 2014 Country Operational Plan (2014). Cameroon 2014 Country Operational Plan report.

Cameroon National AIDS Control Committee – Central Technical Group (2010). The impact of HIV and AIDS in Cameroon through 2020. Central Technical Group. pp. 1-30.

Costa BZ, Machado CG, Avelino MM, Filho GC, Macedo Filho VJ, Ana L Minuzzi LA, Turchi DM, Stefani MA, Souza DVW, Martelli MTC (2009). Prevalence and risk factors for Hepatitis C and HIV-1 infections among pregnant women in Central Brazil. BMC Infect. Dis. 9:116. Crossref

Faul F, Erdfelder E, Buchner A, Lang AG (2009). Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses. Behav. Res. Methods 41:1149-1160. Crossref

Faul F, Erdfelder E, Lang AG, Buchner A (2007). G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav. Res. Methods 39(2):175-191. Crossref

Halle MP, Choukem SP, Kaze FF, Ashuntantang G, Tchamago V, Mboue-Djieka Y, Temfack E, Luma HN (2016). Hepatitis B, Hepatitis C, and Human Immune deficiency Virus Seroconversion Positivity Rates and Their Potential Risk Factors Among Patients on Maintenance Hemodialysis in Cameroon. Iran J. Kidney Dis. 10(5):304-309.

Kim AY, Lauer GM, Ouchi K, Addo MM, Lucas M, Schulze Zur Wiesch J, Timm J, Boczanowski M, Duncan JE, Wurcel AG, Casson D, Chung RT, Draenert R, Klenerman P, Walker BD (2005). The magnitude and breadth of hepatitisC virus-specific CD8+Tcells depend on absolute CD4+T-cell count inindividuals coinfected with HIV-1. Blood 105(3):1170-118. Crossref

Laperche S, Le Marrec N, Girault A, Bouchardeau F, Servant-Delmas A, Maniez-Montreuil M, Gallian P, Levayer T, Morel P, Simon N (2005). Simultaneous detection of hepatitis C virus (HCV) core antigen and anti-HCV antibodies improves the early detection of HCV infection. J. Clin. Microbiol. 43:3877-3883. Crossref

Luma HN, Eloumou SA, Ekaney DS, Lekpa FK, Donfack-Sontsa O, Ngahane BH, Mapoure YN (2016a). Sero-prevalence and Correlates of Hepatitis B and C Co-infection Among HIV-infected Individuals in Two Regional Hospitals in Cameroon. Open AIDS J. 10:199-208. Crossref

Luma HN, Eloumou SA, Malongue A, Temfack E, Noah DN, Donfack-Sontsa O, Ditah IC (2016b). Characteristics of anti-hepatitis C virus antibody-positive patients in a hospital setting in Douala, Cameroon. Int. J. Infect. Dis. 45:53-58. Crossref

Mabala R (2006). From HIV prevention to protection : addressing the vulnerability of girls and young women in urban areas. Environ. Urban 18(2):407-432. Crossref

Mbanya D, Sama M, Tchounwou P (2008). Current Status of HIV/AIDS in Cameroon: How Effective are Control strategies. Int. J. Environ. Res. Public Health 5(5):378-383. Crossref

National Institute of Statistics (2011). Cameroon Demographic and Health Survey and Multiple Indicators Cluster Survey. HIV prevalence and associated factors. DHS-MICS 265-285.Available at: View

Nebout N (1994). Lumière sur le SIDA. Classiques Africains P 48.

Nerrienet E, Pouillot R, Lachenal G, Njouom R, Mfoupouendoun J, Bilong C, Mauclere P, Pasquier C, Ayouba A (2005). Hepatitis C virus infection in cameroon: A cohort-effect. J. Med. Virol. 76(2):208-214. Crossref

Njouom R, Tejiokem M (2016). Epidémiologie des hépatites virales B, C et Delta au Cameroun : analyses des échantillons de l'enquête démographique de santé 2011. Etude ARNS 12289. Journées scientifiques du site Agence de Recherche Nationale sur le SIDA (ARNS-Cameroun); VIème Edition 66-67. Please provide source of reference.

Noubiap JJN, Aka PV, Nanfack AJ, Agyingi LA, Ngai JN, Nyambi PN (2015). Hepatitis B and C Co-Infections in Some HIV-Positive Populations in Cameroon, West Central Africa: Analysis of Samples Collected Over More Than a Decade. PLoS One 10(9):e0137375. Crossref

Noubiap JJN, Joko WYA, Nanseu JRN, Tene UG, Siaka C (2013). Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edea, Cameroon. Int. J. Infect. Dis. 17:e832-e837. Crossref

Pepin J, Lavoie M, Pybus GO, Pouillot R, Foupouapouognigni Y, Rousset D, Labbe AC, Njouom R (2010). Risk Factors for Hepatitis C Virus Transmission in Colonial Cameroon. Clin. Infect. Dis. 51(7):768-776. Crossref

Ramjee G, Daniels B (2013). Women and HIV in Sub-Saharan Africa. AIDS Res. Ther. 10(1):30. Crossref

Soriano V, Martin-Carbonero L, Vispo E, Labarga P, Barreiro P (2011). Human immunodeficiency virus infection and viral hepatitis. Enferm. Infect. Microbiol. Clin. 29(9):691-701. Crossref

Tagny CT, Mbanya D, Murphy EL, Lefrère J-J, Laperche S (2014). Screening for hepatitis C virus infection in a high prevalence country by an antigen/antibody combination assay versus a rapid test. J. Virol. Methods 199:119-123. Crossref

United Nations Programme on HIV/AIDS (UNAIDS) (2016). Global AIDS Update 2016. Available at: View

World Health Organization (WHO) (2013). Global policy report on the prevention and control of viral hepatitis in WHO Member States: ISBN 978 92 4 156463 2.